Trial assesses CD22 CAR T-cell therapy for children, young adults with acute lymphoblastic leukemia – Healio
|
Trial assesses CD22 CAR T-cell therapy for children, young adults with acute lymphoblastic leukemia
Healio The PLAT-04 clinical trial is underway to evaluate the use of CD22 chimeric antigen receptor T-cell immunotherapy for children and young adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia. Study participants will receive CD22 … |
